Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00348387 | Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV | PHASE3 | COMPLETED | 600 | — | — | Jun 1, 2006 | Dec 1, 2008 | Jan 22, 2014 | 2 | China |
| Arm | Type | Description |
|---|---|---|
| Group 1 | EXPERIMENTAL | - |
| Group 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Poliomyelitis Vaccine inactivated | BIOLOGICAL | 0.5 mL, Intramuscular |
| Poliomyelitis Vaccine in Dragee Candy (Human Diploid Cell) | BIOLOGICAL | 1g dragee, oral |
Inclusion Criteria: * Aged 2 months (60-70 days) on the day of inclusion into the study * Born at full term pregnancy ( over 36 weeks) with a birth weight ≥ 2.5 kg 2Ibs) or more * Parent(s) or legal representative able to understand and give authorization and sign informed consent for participation...